PHAT EBITDA Growth
Phathom Pharmaceuticals Inc · EBITDA Growth
PHAT EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported86.31%period ending
PHAT TTM EBITDA YoY % (-32005.23% → 86.31%)
Year-over-year change
High-resolution chart · PNG
PHAT ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 86.315% | |
| 66.5986% | |
| 41.6883% | |
| 25.2196% | |
| -7.7327% | |
| -38.7886% | |
| -64.4286% | |
| -97.2987% | |
| -62.5755% | |
| -22.1828% | |
| 6.3305% | |
| 12.3649% | |
| 2.8181% | |
| -13.8851% | |
| -24.3267% | |
| -0.927% | |
| 1.8415% | |
| -1.9049% | |
| -9.9833% | |
| 7.591% | |
| 23.997% | |
| 47.8105% | |
| 49.4404% | |
| -13.1985% | |
| -142.7702% | |
| -33,910.5263% | |
| -32,005.2288% |